{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:41:54Z","timestamp":1794120114451,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023662","name":"University of Virginia School of Nursing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ypmed.2026.108604","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:09:30Z","timestamp":1779376170000},"page":"108604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial"],"prefix":"10.1016","volume":"209","author":[{"given":"Hyesong H.","family":"Joung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2026.108604_bb0005","unstructured":"Administration for Community Living. n.d. Retrieved February 10, 2025. http:\/\/acl.gov\/aging-and-disability-in-america\/data-and-research\/profile-older-americans."},{"key":"10.1016\/j.ypmed.2026.108604_bb0010","author":"American Cancer Society"},{"key":"10.1016\/j.ypmed.2026.108604_bb0015","author":"American Urological Association"},{"issue":"12","key":"10.1016\/j.ypmed.2026.108604_bb0020","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/jamaoncol.2023.4447","article-title":"Risk Model\u2013Based Lung Cancer Screening and Racial and Ethnic Disparities in the US","volume":"9","author":"Choi","year":"2023","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ypmed.2026.108604_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4111\/icu.20240456","article-title":"Evaluating prostate Cancer diagnostic methods: the role and relevance of digital rectal examination in modern era","volume":"66","author":"Chung","year":"2025","journal-title":"Investigative and Clinical Urology"},{"issue":"11","key":"10.1016\/j.ypmed.2026.108604_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70979","article-title":"Understanding racial disparities in prostate cancer: a multifaceted approach","volume":"14","author":"Cobbs","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.ypmed.2026.108604_bb0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.urology.2022.02.025","article-title":"Prostate cancer disparities in Hispanics using the National Cancer Database","volume":"165","author":"Del Pino","year":"2022","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ypmed.2026.108604_bb0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.pec.2021.09.012","article-title":"Decision-making support among racial and ethnic minorities diagnosed with breast or prostate Cancer: A systematic review of the literature","volume":"105","author":"DeRosa","year":"2022","journal-title":"Patient Educ. Couns."},{"issue":"3","key":"10.1016\/j.ypmed.2026.108604_bb0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00345-020-03242-8","article-title":"PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions","volume":"39","author":"Deuker","year":"2021","journal-title":"World. J. Urol."},{"issue":"6","key":"10.1016\/j.ypmed.2026.108604_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/diseases13060167","article-title":"Overdiagnosis and overtreatment in prostate Cancer","volume":"13","author":"Dushimova","year":"2025","journal-title":"Diseases"},{"issue":"11","key":"10.1016\/j.ypmed.2026.108604_bb0055","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1158\/1055-9965.EPI-24-0678","article-title":"Prostate Cancer disparities in clinical characteristics and survival among Black and Latino patients considering nativity: findings from the California Cancer registry","volume":"33","author":"Freedland","year":"2024","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108604_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amepre.2023.08.005","article-title":"Racial disparities in prostate Cancer screening: the role of shared decision making","volume":"66","author":"Frego","year":"2024","journal-title":"Am. J. Prev. Med."},{"issue":"18","key":"10.1016\/j.ypmed.2026.108604_bb0065","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate Cancer: US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108604_bb0070","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1200\/OP.21.00412","article-title":"Prostate cancer disparities in risk group at presentation and access to treatment for Asian Americans, native Hawaiians, and Pacific Islanders: A study with disaggregated ethnic groups","volume":"18","author":"Jain","year":"2022","journal-title":"JCO Oncol. Pract."},{"issue":"2","key":"10.1016\/j.ypmed.2026.108604_bb0075","article-title":"Bridging the gap: the role of shared decision-making in addressing racial and ethnic disparities in prostate-specific antigen screening","volume":"53","author":"Joung","year":"2026","journal-title":"Oncol. Nurs. Forum"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108604_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13187-017-1211-x","article-title":"Determinants of Cancer screening disparities among Asian Americans: A systematic review of public health surveys","volume":"33","author":"Jun","year":"2018","journal-title":"J. Cancer Educ."},{"issue":"6","key":"10.1016\/j.ypmed.2026.108604_bb0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djaa171","article-title":"Racial and ethnic variation in PSA testing and prostate Cancer incidence following the 2012 USPSTF recommendation","volume":"113","author":"Kensler","year":"2020","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.ypmed.2026.108604_bb0090","first-page":"485","article-title":"Prostate cancer statistics","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ypmed.2026.108604_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/10732748231202462","article-title":"Cancer screening rates among Asian Americans: A cross-sectional secondary data analysis study","volume":"30","author":"Lei","year":"2023","journal-title":"Cancer Control"},{"issue":"10","key":"10.1016\/j.ypmed.2026.108604_bb0100","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jval.2023.06.003","article-title":"Comparisons of medical cost trajectories between non-Hispanic Black and non-Hispanic white patients with newly diagnosed localized prostate Cancer","volume":"26","author":"Liu","year":"2023","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108604_bb0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2023.12.005","article-title":"Comparing the performance of digital rectal examination and prostate-specific antigen as a screening test for prostate Cancer: A systematic review and Meta-analysis","volume":"7","author":"Matsukawa","year":"2024","journal-title":"European Urology Oncology"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108604_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/pon.70145","article-title":"Patient activation and shared decision-making among Hispanics\/Latinos with metastatic Cancer: A qualitative study","volume":"34","author":"Meguro","year":"2025","journal-title":"Psycho-Oncology"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108604_bb0115","doi-asserted-by":"crossref","DOI":"10.1177\/23814683211014180","article-title":"Improving shared decision making in Latino men with prostate Cancer: A thematic analysis","volume":"6","author":"Michel","year":"2021","journal-title":"MDM POLICY & PRACTICE"},{"issue":"11","key":"10.1016\/j.ypmed.2026.108604_bb0120","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/pros.23540","article-title":"Secondary prostate Cancer screening outcomes by race in the prostate, lung, colorectal, and ovarian (PLCO) screening trial","volume":"78","author":"Miller","year":"2018","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.ypmed.2026.108604_bb0125","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bju.14580","article-title":"Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized Cancer screening trial","volume":"123","author":"Pinsky","year":"2019","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.ypmed.2026.108604_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkae016","article-title":"Racial differences in postpandemic trends in prostate-specific antigen screening","volume":"8","author":"Qian","year":"2024","journal-title":"JNCI Cancer Spectr."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108604_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eururo.2022.11.023","article-title":"Disparities and trends in genitourinary Cancer incidence and mortality in the USA","volume":"84","author":"Schafer","year":"2023","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108604_bb0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.22454\/FamMed.2022.474827","article-title":"Physician attitudes and self-reported practices toward prostate Cancer screening in Black and white men","volume":"54","author":"Shungu","year":"2022","journal-title":"Fam. Med."},{"key":"10.1016\/j.ypmed.2026.108604_bb0145","author":"Surveillance, Epidemiology, and End Results Program (SEER)"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108604_bb0150","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41391-023-00676-0","article-title":"Guidelines for genetic testing in prostate Cancer: A scoping review","volume":"27","author":"Tuffaha","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108604_bb0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.56825","article-title":"Trends in prostate cancer incidence and mortality rates","volume":"8","author":"Van Blarigan","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108604_bb0160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/JU.0000000000003603","article-title":"Free PSA and clinically significant and fatal prostate Cancer in the PLCO screening trial","volume":"210","author":"Yim","year":"2023","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.ypmed.2026.108604_bb0165","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0895-4356(94)90170-8","article-title":"Evidence of the depletion of Susceptibles effect in non-experimental Pharmacoepidemiologic research","volume":"47","author":"Yola","year":"1994","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.ypmed.2026.108604_bb0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","article-title":"Epidemiology and genomics of prostate cancer in Asian men","volume":"18","author":"Zhu","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"11","key":"10.1016\/j.ypmed.2026.108604_bb0175","doi-asserted-by":"crossref","first-page":"e2442451","DOI":"10.1001\/jamanetworkopen.2024.42451","article-title":"US Cancer mortality trends among Asian and Pacific islander populations","volume":"7","author":"Zhu","year":"2024","journal-title":"JAMA Netw. Open"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:00:15Z","timestamp":1780966815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743526001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0091743526001106"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108604","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108604"}}